Credit Suisse Starts Esperion Therapeutics (ESPR) at Outperform

July 22, 2013 6:57 AM EDT
Get Alerts ESPR Hot Sheet
Price: $11.69 -1.52%

Rating Summary:
    6 Buy, 5 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 17 | Down: 27 | New: 7
Trade ESPR Now!
Join SI Premium – FREE
Credit Suisse initiates coverage on Esperion Therapeutics (NASDAQ: ESPR) with a Outperform. PT $23.00.

For an analyst ratings summary and ratings history on Esperion Therapeutics click here. For more ratings news on Esperion Therapeutics click here.

Shares of Esperion Therapeutics closed at $17.28 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

New Coverage

Related Entities

Credit Suisse

Add Your Comment